Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction
NCT ID: NCT03834610
Last Updated: 2019-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2017-10-01
2018-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction
NCT05884957
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
NCT06583590
Daily Tadalafil in Diabetic ED Patients
NCT06962462
Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study
NCT06947265
Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction
NCT05446493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
receive L-arginine 5 g oral caps daily for 8 weeks serum testosterone level measurement penile doppler
L-arginine 5 gm oral caps
oral L-arginine 5 gm daily for 8 weeks
serum testosterone level
measurement of serum testosterone level
HbA1C
measurement of HbA1C levels
penile doppler
penile doppler to measure the degree of erection and penile vasculature
Group B
receive tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler
Tadalafil 10 MG
oral daily tadalafil 10mg for 8 weeks
serum testosterone level
measurement of serum testosterone level
HbA1C
measurement of HbA1C levels
penile doppler
penile doppler to measure the degree of erection and penile vasculature
Group C
receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler
L-arginine 5 gm oral caps
oral L-arginine 5 gm daily for 8 weeks
Tadalafil 10 MG
oral daily tadalafil 10mg for 8 weeks
serum testosterone level
measurement of serum testosterone level
HbA1C
measurement of HbA1C levels
penile doppler
penile doppler to measure the degree of erection and penile vasculature
Group D
receive oral methyl cellulose daily for 8 weeks serum testosterone level measurement penile doppler
serum testosterone level
measurement of serum testosterone level
HbA1C
measurement of HbA1C levels
penile doppler
penile doppler to measure the degree of erection and penile vasculature
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-arginine 5 gm oral caps
oral L-arginine 5 gm daily for 8 weeks
Tadalafil 10 MG
oral daily tadalafil 10mg for 8 weeks
serum testosterone level
measurement of serum testosterone level
HbA1C
measurement of HbA1C levels
penile doppler
penile doppler to measure the degree of erection and penile vasculature
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
35 Years
56 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aswan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moustafa A. El Taieb
Ass. Prof. of Dermatology, Venereology and Andrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moustafa M El Taieb, MD
Role: PRINCIPAL_INVESTIGATOR
Aswan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan University Hospital
Aswān, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L-arginine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.